WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007002173) HIV-1 PROTEASE INHIBITORS, AND METHODS OF MAKING AND USING THEM
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/002173    International Application No.:    PCT/US2006/024109
Publication Date: 04.01.2007 International Filing Date: 21.06.2006
IPC:
C07D 263/24 (2006.01), A61K 31/421 (2006.01), A61P 31/18 (2006.01)
Applicants: UNIVERSITY OF MASSACHUSETTS [US/US]; One Beacon Street, 26th Floor, Boston, Massachusetts 02108 (US) (For All Designated States Except US).
RANA, Tariq, M. [US/US]; (US) (For US Only).
ALI, Akbar [PK/US]; (US) (For US Only).
CAO, Hong [CN/US]; (US) (For US Only).
SAI, Kiran Kumar Reddy Ga [IN/US]; (US) (For US Only).
ANJUM, Saima, Ghafoor [PK/US]; (US) (For US Only)
Inventors: RANA, Tariq, M.; (US).
ALI, Akbar; (US).
CAO, Hong; (US).
SAI, Kiran Kumar Reddy Ga; (US).
ANJUM, Saima, Ghafoor; (US)
Agent: WASSERMAN, Jacob, I.; Patent Group, Foley Hoag LLP, 155 Seaport Boulevard, Boston, MA 02210-2600 (US)
Priority Data:
60/693,134 22.06.2005 US
60/749,902 12.12.2005 US
60/810,234 02.06.2006 US
Title (EN) HIV-1 PROTEASE INHIBITORS, AND METHODS OF MAKING AND USING THEM
(FR) INHIBITEURS DE LA PROTEASE DU VIH-1, ET LEURS PROCEDES DE FABRICATION ET D'UTILISATION
Abstract: front page image
(EN)One aspect of the invention relates to the design, synthesis and biological activity of novel HIV-1 protease inhibitors incorporating N-phenyloxazolidine-5-carboxamides into the (hydroxyethylamino)sulfonamide scaffold as P2 ligands. For example, the present invention relates to inhibitors with variations at the P2 phenyloxazolidine and the P2' phenylsulfonamide moieties. Remarkably, compounds with an (S)-enantiomer of substituted phenyloxazolidines at P2 show highly potent inhibitory activities against wild-type HIV-1 protease. In certain embodiments, the inhibitors of the invention have Ki values in low picomolar (pM) range. In certain embodiments, the inhibitors of the invention were shown to be active against a variety of multi-drug resistant (MDR) HIV-1 proteases, each representing different paradigm of drug resistance.
(FR)L'invention concerne, dans un aspect, la conception, la synthèse et l'activité biologique de nouveaux inhibiteurs de la protéase du VIH-1 incorporant N-phényloxazolidine-5-carboxamides dans le squelette (hydroxyéthylamino)sulfonamide comme ligands P2. Par exemple, l'invention concerne des inhibiteurs présentant des variations au niveau des fractions de P2 phényloxazolidine et de P2' phénylsulfonamide. A relever que des composés avec un (S)-énantiomère de phényloxazolines substituées à P2 présentent des activités inhibitrices particulièrement puissantes contre la protéase de VIH-1 de type sauvage. Dans certains modes de réalisation, les inhibiteurs ont des valeurs Ki dans une gamme picomolaire basse (pM). D'autres modes de réalisation montrent des inhibiteurs actifs contre une variété de protéases du VIH-1 résistantes à plusieurs médicaments (MDR), chacun représentant un paradigme différent de résistance aux médicaments.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)